Immunoglobulin G4-associated cholangitis

Current Opinion in Gastroenterology

Volumn 24, Issue 3, 2008, Pages 389-394

  Björnsson, Einar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmune pancreatitis; Biliary strictures; Corticosteroids; Immunoglobulin G4; Immunopathology; Primary sclerosing cholangitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G4; INTERLEUKIN 10; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE PANCREATITIS; BILE DUCT; BILE DUCT CARCINOMA; CELL INFILTRATION; CHOLANGITIS; CLINICAL FEATURE; DRUG DOSE REDUCTION; ENTERITIS; HELPER CELL; HUMAN; IMMUNITY; IMMUNOGLOBULIN G4 ASSOCIATED CHOLANGITIS; IMMUNOHISTOCHEMISTRY; LIVER HISTOLOGY; PATHOGENESIS; PLASMA CELL; PROGNOSIS; RELAPSE; REVIEW; STENT; UPREGULATION;

ADRENAL CORTEX HORMONES; CHOLANGIOGRAPHY; CHOLANGITIS; HUMANS; IMMUNOGLOBULIN G; PROGNOSIS; STENTS;

EID: 42149152664     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282f6a7c5     Document Type: Review

References (37)

1. Björnsson E, Chari S, Smyrk T, Lindor K. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007; 45:1547-1554. This is the first review published on IAC.
2. Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: the latest addition to the sclerosing cholangitis family. Hepatol Res 2007; 37 (Suppl 3):S478-S486. A comprehensive review of the pathology and immunopathology of IAC.
3. Kawa S, Hamano H, Umemura T, et al. Sclerosing cholangitis associated with autoimmune pancreatitis. Hepatol Res 2007; 37 (Suppl 3):S487-S495. A comprehensive review of IAC associated with AIP.
4. Umemura T, Zen Y, Hamano H, et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46:463-471. An important study showing the importance of a liver biopsy in the diagnostic workup of AIP.
5. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45:1538-1546. This important study explored the immunopathogenesis of AIC.
6. Harada K, Van de Water J, Leung PS, et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25:791-796.
7. Lit LC, Wong CK, Li EK, et al. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 2007; 34:89-96.
8. Maloy KJ, Salaun L, Cahill R, et al. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197:111-119.
9. Robinson DS, Larché M, Durham SR. Tregs and allergic disease. J Clin Invest 2004; 114:1389-1397.
10. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6:353-360.
11. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994; 6:838-846.
12. Nouri-Aria KT, Wachholz PA, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004; 172:3252-3259.
13. Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology 2005; 47:147-158.
14. Morell A, Skvaril F, Hitzig WH, Barandun S. IgG subclasses: development of the serum concentrations in 'normal' infants and children. J Pediatr 1972;80:960-964.
15. Rock B, Martins CR, Theofilopoulos A, et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 1989; 320:1463-1469.
16. Aalberse RC, Van Milligen F, Tan KY, Stapel SO. Allergen-specific IgG4 in atopic disease. Allergy 1993; 48:559-569.
17. Evengård B, Wolowczuk I, Marguerite M, et al. IgG subclass-associated differences in antischistosomal antibody specificity. Scand J Immunol 1994;40:618-622.
18. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732-738.
19. Hirano K, Shiratori Y, Komatsu Y, et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol 2003;1:453-464.
20. Deheragoda MG, Church NI, Rodriguez-Justo M, et al. The use of immunoglobulin G4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol 2007;5:1229-1234. This study investigates the importance of immunostaining of IgG4-related lesions for the diagnostic work-up of suspected AIP and IAC.
21. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007; 102:2417-2425. This study demonstrated that a significant proportion of AIP and IAC patients show relapse after tapering of steroids which has not been documented earlier.
22. Kim KP, Kim MH, Lee SS, et al. Autoimmune pancreatitis: it may be a worldwide entity. Gastroenterology 2004; 126:1214.
23. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006; 4:1010-1016.
24. Hirano K, Kawabe T, Yamamoto N, et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta 2006; 367 (1-2):181-184. This study investigating IgG4 levels in a large number of different liver and biliary disorders shows that a significant proportion of PSC patients have elevated IgG4 levels and that these patients can also have IBD, and that these PSC patients with high IgG4 can have a severe liver disease requiring a liver transplantation.
25. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006;4:1010-1016. This is the first study investigating the levels of IG4 in a large number of PSC patients and shows that almost 10% of PSC patients can have elevated IgG4 levels.
26. Takikawa H, Takamori Y, Tanaka A, et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan: presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004; 29:153-159.
27. Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 2007;56:1471-1472.
28. Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007; 42:550-559.
29. Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 2004; 60:937-944.
30. Ludwig J. Histopathology of primary sclerosing cholangitis. In: Manns M, Chapman RW, Stiehl A, Wiesner R, editors. Primary sclerosing cholangitis. London: Kluwer Academic Publishers; 1998. pp. 14-21.
31. Hamano H, Umemura T, Uehara T, et al. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol 2007; 102:691-692.
32. Lindor KD, LaRusso NF. Primary sclerosing cholangitis. In: Schiff ER, Sorell MF, Maddrey WC, editors. Schiff's diseases of the liver, 9th ed. Philadelphia: Lippincott William & Wilkins; 2003. pp. 673-684.
33. Björnsson E, Boberg KM, Cullen S, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002; 51:731-735.
34. Floreani A, Rizzotto ER, Ferrara F, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005; 100:1516-1522.
35. Erkelens GW, Vleggaar FP, Lesterhuis W, et al. Sclerosing pancreatocholangitis responsive to steroid therapy. Lancet 1999; 354:43-44.
36. Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 2001;48:625-630.
37. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005; 30:76-82.